Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,762
datasets available to search
ShareScore release 0.9.0
Dataset results
3,762 results for “Combination treatment”
A Phase III, Randomized, Clinical Trial of GnP Combined With SBRT and Serplulimab Versus GnP as First-Line Treatment for Patients With Recurrent or Metastatic Pancreatic Cancer (WGOG-PAN 006/ICSBR-2)
ClinicalTrials.gov study NCT07336953. IPD Sharing: NO. Countries: 0. Publications: 0.
Chidamide Combined With Azacitidine and Mitoxantrone Liposome in the Treatment of Relapsed/Refractory (nTFHL)
ClinicalTrials.gov study NCT05772728. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study of QL1706 (an Anti-PD-1/CTLA-4 Combined Antibody) Combined With Albumin-bound Paclitaxel and Bevacizumab in the Treatment of Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT06509971. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Safety and Tolerability Analysis of Combining Desmopressin With Docetaxel for the Treatment of Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT04113005. IPD Sharing: NO. Countries: 0. Publications: 0.
Evaluation of the Efficacy of Intense Pulse Light Combined With Lipiflow in the Treatment of Meibomian Gland Dysfunction
ClinicalTrials.gov study NCT04633798. IPD Sharing: NO. Countries: 0. Publications: 0.
Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC
ClinicalTrials.gov study NCT06732258. IPD Sharing: NO. Countries: 0. Publications: 0.
Phase II Study of Nivolumab in Combination With Radiation Therapy as Definitive Treatment for Patients With Locally Advanced, Unresectable Head and Neck Mucosal Melanoma.
ClinicalTrials.gov study NCT03758729. IPD Sharing: Not stated. Countries: 0. Publications: 0.
The Combination of Zanubrutinib and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
ClinicalTrials.gov study NCT05369364. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Nimotuzumab Combined With Neoadjuvant Chemotherapy in the Treatment of Resectable LA HNSCC
ClinicalTrials.gov study NCT05351762. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer
ClinicalTrials.gov study NCT06653972. IPD Sharing: YES. Countries: 0. Publications: 0.
Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer
ClinicalTrials.gov study NCT07107217. IPD Sharing: NO. Countries: 0. Publications: 0.
Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma
ClinicalTrials.gov study NCT07276737. IPD Sharing: NO. Countries: 0. Publications: 0.
Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric Cancer
ClinicalTrials.gov study NCT05385900. IPD Sharing: NO. Countries: 0. Publications: 0.
A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell
ClinicalTrials.gov study NCT06746870. IPD Sharing: NO. Countries: 0. Publications: 0.
Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia
ClinicalTrials.gov study NCT05798390. IPD Sharing: NO. Countries: 0. Publications: 0.
SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC
ClinicalTrials.gov study NCT05732662. IPD Sharing: Not stated. Countries: 0. Publications: 0.
QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors
ClinicalTrials.gov study NCT03169738. IPD Sharing: NO. Countries: 0. Publications: 0.
HIPEC Combined With SOX and Sintilimab in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
ClinicalTrials.gov study NCT06213519. IPD Sharing: NO. Countries: 0. Publications: 0.
Adebrelimab Combined with Chemotherapy and Thoracic Radiotherapy for First-line Treatment of ES-SCLC
ClinicalTrials.gov study NCT06672133. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety and Efficacy of G17DT Immunogen Combined With Gemcitabine vs. Gemcitabine in the Treatment of Advanced Pancreatic Carcinoma
ClinicalTrials.gov study NCT00044031. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.